INVESTMENT COMPONENT
Modernization
Recapitalization
Maintenance
Delivers safe, effective, and robust medical products that protect U.S. forces against validated chemical, biological, radiological, and nuclear (CBRN) threats by applying government and industry best practices to develop or acquire Food and Drug Administration (FDA) approved products.
Components of the Next Generation Diagnostic System (NGDS) Family of Systems (FoS) will be deployed to all Roles (I through III) of combat health support for use during peace time and combat across the full spectrum of military operations. NGDS will be used within the continental U.S. (CONUS) and outside the continental U.S. (OCONUS) by forward deployed units, mobile hospitals and laboratories. NGDS is intended to mitigate the effects of personnel exposure to biological warfare agents and endemic infectious disease through rapid near real-time diagnostics.
None
ACQUISITION PHASE
Technology Development
Engineering & Manufacturing Development
Production & Deployment
Operations & Support
None
To be determined
